Beth A. Taylor

CIK 1522046 · Chief Financial Officer · last filed 2026-02-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$11.6K

Companies

3

Total Filings

34

Lifetime Open-Market Net

$12.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NOTV Chief Financial Officer 145,480 $0.08 $11.6K $137.7K 15 2026-02-19
Inotiv, Inc. (BASI) Delisted VP- Finance & CFO 34,295 $16.44 $563.8K $147.4K 4 2021-03-05
ENDOCYTE INC (ECYT) Delisted VP Finance & Chief Acctg Off 0 -$272.3K 15 2018-12-21

Recent Filings · Page 2 of 4

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-02-17 NOTV Grant (A) +40,000 $0 EDGAR
2021-12-20 NOTV Grant (A) +214 $0 EDGAR
2021-10-26 NOTV Grant (A) +1,332 $0 EDGAR
2021-05-17 NOTV Buy (P) +2,154 $49.8K EDGAR
2021-05-11 NOTV Grant (A) +880 $0 EDGAR
2021-03-05 Inotiv, Inc. (BASI) Delisted Buy (P) +5,000 $88.5K EDGAR
2020-12-04 Inotiv, Inc. (BASI) Delisted Grant (A) +5,995 $0 EDGAR
2020-06-11 Inotiv, Inc. (BASI) Delisted Grant (A) +10,000 $0 EDGAR
2020-05-21 Inotiv, Inc. (BASI) Delisted Buy (P) +13,300 $58.9K EDGAR
2018-12-21 ENDOCYTE INC (ECYT) Delisted Disp (D) −99,509 -$2.39M EDGAR
Showing 1120 of 34
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.